Cargando…

Dickkopf-related protein 3 promotes pathogenic stromal remodeling in benign prostatic hyperplasia and prostate cancer

BACKGROUND Compartment-specific epithelial and stromal expression of the secreted glycoprotein Dickkopf-related protein (Dkk)-3 is altered in age-related proliferative disorders of the human prostate. This study aimed to determine the effect of Dkk-3 on prostate stromal remodeling that is stromal pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zenzmaier, Christoph, Sampson, Natalie, Plas, Eugen, Berger, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals 2013
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842835/ https://www.ncbi.nlm.nih.gov/pubmed/23765731 http://dx.doi.org/10.1002/pros.22691

Ejemplares similares

Elevated levels of Dickkopf-related protein 3 in seminal plasma of prostate cancer patients
por: Zenzmaier, Christoph, et al.
Publicado: (2011)

The Symptoms of Benign Prostatic Hyperplasia Patients with Stromal-Dominated Hyperplasia Nodules May Be Associated with Prostate Fibrosis
por: Cao, Ying, et al.
Publicado: (2023)

Mechanism of Androgen-Independent Stromal Proliferation in Benign Prostatic Hyperplasia
por: Hata, Junya, et al.
Publicado: (2023)

Benign Prostatic Hyperplasia
Publicado: (2015)

Androgen Receptor Expression in Epithelial and Stromal Cells of Prostatic Carcinoma and Benign Prostatic Hyperplasia
por: Filipovski, Vanja, et al.
Publicado: (2017)

Stimulation of prostate cells by the senescence phenotype of epithelial and stromal cells: Implication for benign prostate hyperplasia
por: Jiang, Shoulei, et al.
Publicado: (2019)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Prostatic Stromal Hyperplasia with Atypia
por: Hutchinson, Ryan C., et al.
Publicado: (2013)

Therapeutic Targeting of Redox Signaling in Myofibroblast Differentiation and Age-Related Fibrotic Disease
por: Sampson, Natalie, et al.
Publicado: (2012)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk
por: Hung, S-C, et al.
Publicado: (2013)

Leptin Mediates Prostate Stromal Cell Proliferation, Smooth Muscle Contraction, and Mitochondrial Function in Benign Prostate Hyperplasia
por: Wang, Xiaolong, et al.
Publicado: (2023)

Estrogen regulates the proliferation and inflammatory expression of primary stromal cell in benign prostatic hyperplasia
por: Chen, Bo, et al.
Publicado: (2020)

Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma
por: Christudoss, Pamela, et al.
Publicado: (2011)

Expression and Localization of Aquaporins in Benign Prostate Hyperplasia and Prostate Cancer
por: Hwang, Insang, et al.
Publicado: (2012)

Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia
por: Yu, Haining, et al.
Publicado: (2015)

Rare Variant of Carcinoma Prostate Masquerading as Benign Prostatic Hyperplasia
por: Khanduri, Sachin, et al.
Publicado: (2019)

Prostate sarcomas: A radiological mimic for benign prostatic hyperplasia
por: Whish-Wilson, Thomas, et al.
Publicado: (2020)

Prostate embolization in the treatment of benign prostatic hyperplasia: what’s the point?
por: Nunes, Thiago Franchi, et al.
Publicado: (2021)

Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate Cancer
por: Ratajczak, Weronika, et al.
Publicado: (2022)

Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer
por: Glaser, Alexander, et al.
Publicado: (2022)

Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?
por: Protopsaltis, Ioannis, et al.
Publicado: (2013)

Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients
por: Kim, Sung Han, et al.
Publicado: (2021)

Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.
por: Cohen, P., et al.
Publicado: (1998)

Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.
por: Mantzoros, C. S., et al.
Publicado: (1997)

The Correlation Between Prostate Volume in Patients with Benign Prostatic Hyperplasia in Relation to Erectile Dysfunction
por: Kardasevic, Amel, et al.
Publicado: (2016)

Physical Activity and Benign Prostatic Hyperplasia-Related Outcomes and Nocturia
por: WOLIN, KATHLEEN Y., et al.
Publicado: (2015)

Morphological Changes of Benign Prostatic Hyperplasia in Culture
por: McMahon, M. J., et al.
Publicado: (1973)

Benign Prostatic Hyperplasia: from Bench to Clinic
por: Yoo, Tag Keun, et al.
Publicado: (2012)

VASTI THERAPY IN THE MANAGEMENT OF BENIGN PROSTATE HYPERPLASIA
por: Gupta, Shivaji, et al.
Publicado: (1997)

Current Laser Treatments for Benign Prostatic Hyperplasia
por: Son, Hwancheol, et al.
Publicado: (2010)

Benign prostatic hyperplasia: An overview of existing treatment
por: Dhingra, Neelima, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_abcgda6dopb4nnhndonpdbho6i